Art

J-GLOBAL ID：202102273123872454   Reference number：21A0470917

Can progressive site-directed therapy prolong the efficacy of subsequent androgen receptor axis-targeted drugs in oligometastatic castration-resistant prostate cancer?

進行部位局所治療は,オリゴ転移性去勢抵抗性前立腺癌におけるその後のアンドロゲン受容体軸標的薬の有効性を延長できるか?

Author (7)： Yoshida Soichiro (Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan) ,  Takahara Taro (Department of Biomedical Engineering, Tokai University School of Engineering, Kanagawa, Japan) ,  Takahara Taro (Department of Radiology, Advanced Imaging Center, Yaesu Clinic, Tokyo, Japan) ,  Yokoyama Minato (Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan) ,  Matsuoka Yoh (Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan) ,  Yoshimura Ryoichi (Department of Radiation Therapeutics and Oncology, Tokyo Medical and Dental University, Tokyo, Japan) ,  Fujii Yasuhisa (Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan)
Material： International Journal of Urology (Web)  (Int J Urol (Web))
Volume： 28  Issue： 2  Page： 241-242  Publication year： 2021 
JST Material Number： U0707A  ISSN： 1442-2042  Document type： Article
Article type： 短報  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： *local treatment ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0470917&from=J-GLOBAL&jstjournalNo=U0707A") }}

JST classification (2)： Urogenital tumors(=neoplasms)  (GM04000S) ,  Treatment for tumors in general  (GE03031L)

Terms in the title (5)： 局所治療 ,  転移性去勢抵抗性前立腺癌 ,  アンドロゲン受容体 ,  標的 ,  有効性